Foghorn Therapeutics Inc. (FHTX) Insider Trading & SEC Filings

Updated Jul 16, 2026 · Last SEC filing 2026-06-25

Foghorn Therapeutics Inc. (FHTX) has filed 9 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-06-25. 3 Form 8-K material event filings were reported by FHTX in the last 90 days. InsiderAlpha tracks every FHTX SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.

About Foghorn Therapeutics Inc. (FHTX)

SEC CIK	0001822462

90-Day SEC Filing Activity

Form 4 filings (90d)	9
Form 8-K filings (90d)	3
Latest Form 4 filing	2026-06-25

Recent FHTX Insider Transactions (Form 4)

Date	Insider	Role	Transaction	Shares	Price	Value	Filing
2026-04-10	GOTTSCHALK ADRIAN	Chief Executive Officer	G — Bona-fide gift	59.2K	$0.00	—	SEC
2026-04-10	GOTTSCHALK ADRIAN	Chief Executive Officer	G — Bona-fide gift	59.2K	$0.00	—	SEC
2026-04-09	GOTTSCHALK ADRIAN	Chief Executive Officer	G — Bona-fide gift	47.5K	$0.00	—	SEC
2026-04-09	GOTTSCHALK ADRIAN	Chief Executive Officer	G — Bona-fide gift	47.5K	$0.00	—	SEC

All transactions sourced from SEC EDGAR Form 4 filings for Foghorn Therapeutics Inc. (FHTX). Updated in real time as new filings are submitted to the SEC.

Most-Active FHTX Insiders — Last 90 Days

Insider	Form 4 filings	Total transaction value
SMITH IAN F	1	$114K
PARSHALL B LYNNE	1	$114K
GILL SIMBA	1	$114K
Gallagher Neil	1	$114K
Duty Stuart	1	$114K

Recent FHTX Form 8-K Material Events

2026-06-24 — Item 5.07 [SEC]
2026-05-07 — Item 2.02, 7.01, 9.01 [SEC]
2026-04-21 — Item 7.01, 8.01, 9.01 · Clinical · positive [SEC]
Foghorn Therapeutics announced preclinical data for multiple drug programs presented at the 2026 AACR Annual Meeting, including data on SMARCA2 selective inhibitor FHD-909 and selective CBP, EP300, and ARID1B degrader programs. The company is furnishing an investor presentation a
2026-03-11 — Item 2.02, 7.01, 9.01 · Earnings · neutral [SEC]
Foghorn Therapeutics announced financial results for the year ended December 31, 2025 via press release on March 11, 2026. The filing includes standard annual financial results disclosure and an investor presentation, with no indication of beat/miss relative to expectations.
2026-02-23 — Item 5.02, 8.01, 9.01 · Leadership · neutral [SEC]
Foghorn Therapeutics appointed Ryan D. Maynard as Chief Financial Officer effective immediately, replacing interim CFO Jeff Sacher. Maynard brings extensive experience from prior CFO roles at public biotech companies including Cara Therapeutics, Rigel Pharmaceuticals, and others,

Recent Insider Filings

2026-06-25 — Lynch Thomas J. Jr. (Insider)
2026-06-25 — Duty Stuart (Insider)
2026-06-25 — Biller Scott (Insider)
2026-06-25 — Gallagher Neil (Insider)
2026-06-25 — Mendelsohn Michael (Insider)

Form 4 Transaction Code Reference

SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in FHTX insider filings:

P	Open-market purchase by the insider
S	Open-market sale by the insider
A	Grant, award, or other acquisition from the issuer
M	Exercise or conversion of derivative security (e.g. options)
F	Payment of exercise price or tax liability via share withholding
G	Bona-fide gift of securities
D	Disposition to the issuer (e.g. share buyback participation)
J	Other acquisition or disposition
X	Exercise of in-the-money or at-the-money derivative security
C	Conversion of derivative security
V	Transaction voluntarily reported earlier than required

FHTX Insider Trading — FAQ

What is the latest insider trade for FHTX?: Foghorn Therapeutics Inc. (FHTX) had 9 insider filings in the last 90 days, with the most recent on 2026-06-25. InsiderAlpha tracks every Form 4, 10-K, 10-Q, and 8-K filing in real time.
How many insiders are buying FHTX stock?: 0 insider purchases of FHTX were filed in the last 90 days.
How many insiders are selling FHTX stock?: 0 insider sales of FHTX were filed in the last 90 days.
Where can I see FHTX SEC filings (Form 4, 10-K, 10-Q, 8-K)?: InsiderAlpha aggregates every FHTX SEC filing — Form 4 insider transactions, 10-K and 10-Q quarterly reports, and 8-K material event disclosures — in one timeline.

Learn More

Open the live FHTX dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.